From the AGM preso Dec2020...
....As reported, the recent financing has provided capital to support the preparatory work for the trial up to trial initiation, therefore the major costs associated with the conduct of the trial are not anticipated to come through until later in 2021. In the interim, the company will look at funding options for the trial while continuing with its planned corporate engagement which may present as part of the financing option.
.
- Forums
- ASX - By Stock
- Ann: US FDA Feedback on Type C Meeting for ATL1102 in the US
From the AGM preso Dec2020... ....As reported, the recent...
-
- There are more pages in this discussion • 58 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
MND
Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?
NVA
Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter
Add PER (ASX) to my watchlist
|
|||||
Last
7.3¢ |
Change
-0.002(2.67%) |
Mkt cap ! $65.81M |
Open | High | Low | Value | Volume |
7.3¢ | 7.3¢ | 7.2¢ | $24.33K | 334.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 83420 | 7.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.3¢ | 7464 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 83420 | 0.072 |
2 | 310000 | 0.071 |
4 | 34299 | 0.070 |
2 | 28980 | 0.069 |
3 | 33055 | 0.068 |
Price($) | Vol. | No. |
---|---|---|
0.073 | 7464 | 3 |
0.075 | 37639 | 2 |
0.078 | 125476 | 3 |
0.079 | 175123 | 2 |
0.080 | 287231 | 3 |
Last trade - 12.23pm 29/07/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |